Hillsdale Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $275K | Buy |
+560
| New | +$304K | 0.01% | 531 |
|
|
2025
Q1 | – | Sell |
-372
| Closed | -$194K | – | 708 |
|
|
2024
Q4 | $194K | Sell |
372
-280
| -43% | -$154K | 0.01% | 407 |
|
|
2024
Q3 | $403K | Buy |
652
+261
| +67% | +$155K | 0.03% | 353 |
|
|
2024
Q2 | $216K | Buy |
391
+70
| +22% | +$40.1K | 0.02% | 374 |
|
|
2024
Q1 | $187K | Buy |
321
+60
| +23% | +$33.7K | 0.01% | 377 |
|
|
2023
Q4 | $139K | Sell |
261
-270
| -51% | -$131K | 0.01% | 396 |
|
|
2023
Q3 | $269K | Buy |
531
+163
| +44% | +$86.9K | 0.02% | 336 |
|
|
2023
Q2 | $192K | Hold |
368
| – | – | 0.02% | 323 |
|
|
2023
Q1 | $212K | Sell |
368
-80
| -18% | -$45.1K | 0.02% | 413 |
|
|
2022
Q4 | $247K | Buy |
448
+30
| +7% | +$15.9K | 0.02% | 401 |
|
|
2022
Q3 | $212K | Sell |
418
-18
| -4% | -$10.1K | 0.02% | 390 |
|
|
2022
Q2 | $237K | Sell |
436
-1,040
| -70% | -$572K | 0.02% | 396 |
|
|
2022
Q1 | $872K | Buy |
1,476
+1,210
| +455% | +$695K | 0.06% | 263 |
|
|
2021
Q4 | $177K | Buy |
266
+80
| +43% | +$49.9K | 0.01% | 413 |
|
|
2021
Q3 | $106K | Sell |
186
-1,244
| -87% | -$683K | 0.01% | 433 |
|
|
2021
Q2 | $721K | Buy |
1,430
+50
| +4% | +$23.6K | 0.06% | 300 |
|
|
2021
Q1 | $630K | Buy |
1,380
+90
| +7% | +$43K | 0.05% | 304 |
|
|
2020
Q4 | $600K | Hold |
1,290
| – | – | 0.06% | 291 |
|
|
2020
Q3 | $569K | Buy |
1,290
+1,120
| +659% | +$463K | 0.06% | 291 |
|
|
2020
Q2 | $62K | Sell |
170
-220
| -56% | -$73.7K | 0.01% | 418 |
|
|
2020
Q1 | $111K | Sell |
390
-1,635
| -81% | -$516K | 0.01% | 417 |
|
|
2019
Q4 | $657K | Sell |
2,025
-200
| -9% | -$60.6K | 0.06% | 298 |
|
|
2019
Q3 | $648K | Hold |
2,225
| – | – | 0.06% | 285 |
|
|
2019
Q2 | $654K | Buy |
2,225
+2,055
| +1,209% | +$566K | 0.06% | 280 |
|
|
2019
Q1 | $47K | Buy |
+170
| New | +$42.3K | ﹤0.01% | 430 |
|
|
2018
Q1 | – | Sell |
-1,900
| Closed | -$361K | – | 535 |
|
|
2017
Q4 | $361K | Hold |
1,900
| – | – | 0.06% | 266 |
|
|
2017
Q3 | $359K | Buy |
1,900
+200
| +12% | +$36.2K | 0.06% | 251 |
|
|
2017
Q2 | $297K | Sell |
1,700
-300
| -15% | -$50.4K | 0.06% | 264 |
|
|
2017
Q1 | $307K | Sell |
2,000
-200
| -9% | -$30.6K | 0.06% | 237 |
|
|
2016
Q4 | $310K | Buy |
+2,200
| New | +$324K | 0.06% | 225 |
|
|
2013
Q3 | – | Sell |
-100
| Closed | -$8K | – | 566 |
|
|
2013
Q2 | $8K | Buy |
+100
| New | +$8.32K | ﹤0.01% | 476 |
|
Other funds holding TMO
VCM
Hillsdale Investment Management's TMO Position: Q1 2026 in Review
Hillsdale Investment Management opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 560 shares worth $275K. The stake represents 0.01% of the portfolio and ranks #531 among its holdings. This is a return to the name: Hillsdale Investment Management previously reported a position in TMO as recently as Q4 2024.
Hillsdale Investment Management first reported a position in TMO in Q2 2013 and has held it in 31 quarters since. The position peaked at $872K in Q1 2022. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Hillsdale Investment Management held 560 shares of Thermo Fisher Scientific worth $275K as of Q1 2026.
- Thermo Fisher Scientific was a new Hillsdale Investment Management position in Q1 2026.
- Thermo Fisher Scientific made up 0.01% of Hillsdale Investment Management's portfolio in Q1 2026, its #531 holding.
- Hillsdale Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 31 quarters since.
- Hillsdale Investment Management's Thermo Fisher Scientific position peaked at $872K in Q1 2022.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.